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Abstract
Introduction
Linkage to HIV treatment is a vital step in the cascade of HIV services and is critical to slow-
ing down HIV transmission in countries with high HIV prevalence. Equally, linkage to volun-
tary medical male circumcision (VMMC) has been shown to decrease HIV transmission by
60% and increasing numbers of men receiving VMMC has a substantial impact on HIV inci-
dence. However, only 48% of newly diagnosed HIV positive people link to HIV treatment
let alone access HIV prevention methods such as VMMC globally.
Methods
A systematic review investigating the effect of demand-side financial incentives (DSFIs) on
linkage into HIV treatment or VMMC for studies conducted in low- and middle-income coun-
tries. We searched the title, abstract and keywords in eight bibliographic databases: MED-
LINE, EMBASE, Web of Science, Econlit, Cochrane, SCOPUS, IAS Conference database
of abstracts, and CROI Conference database of abstracts. Searches were done in Decem-
ber 2016 with no time restriction. We fitted random effects (RE) models and used forest
plots to display risk ratios (RR) and 95% CIs separately for the linkage to VMMC outcome.
The RE model was also used to assess heterogeneity for the linkage to HIV treatment
outcome.
Results
Of the 1205 citations identified from searches, 48 full text articles were reviewed culminating
in nine articles in the final analysis. Five trials investigated the effect of DSFIs on linkage to
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HIV treatment while four trials investigated linkage to VMMC. Financial incentives improved
linkage to HIV treatment in three of the five trials that investigated this outcome. Significant
improvements were observed among postpartum women RR 1.26 (95% CI: 1.08; 1.48),
among people who inject drugs RR 1.42 (95% CI: 1.09; 1.96), and among people testing at
the clinic RR 1.10 (95% CI: 1.07; 1.14). One of the two trials that did not find significant
improvement in linkage to ART was among people testing HIV positive in clinics RR 0.96
(95% CI: 0.81; 1.16) while the other was among new HIV positive individuals identified
through a community testing study RR 0.82 (95% CI: 0.56; 1.22).
We estimate an average 4-fold increase in the uptake of circumcision among HIV negative
uncircumcised men from our fitted RE model with overall RR 4.00 (95% CI: 2.17; 7.37). There
was negligible heterogeneity in the estimates from the different studies with I-squared = 0.0%;
p = 0.923.
Conclusions
Overall, DSFIs appeared to improve linkage for both HIV treatment and VMMC with greater
effect for VMMC. Demand-side financial incentives could improve linkage to HIV treatment
or VMMC in low- and middle-income countries although uptake by policy makers remains a
challenge.
Introduction
There are approximately 1.1 million deaths every year due to HIV infection worldwide with an
estimated 1.9 million annual incident infections, the majority in low- and middle-income
countries (LMIC)[1]. Nearly 40% of people living with HIV (PLWH) who were newly diag-
nosed HIV positive were reported to link into HIV care in a recent systematic review [2]. The
benefits of timely initiation of ART [3] and effective HIV prevention including voluntary med-
ical male circumcision (VMMC) [4,5,6,7] have changed the emphasis of HIV testing and ser-
vices (HTS) from learning one’s status to appropriate linkage and retention [1]. Uptake of
HTS and linkage into care or prevention remains below current targets [8] in most LMIC [9].
Modeling studies showed that circumcising 80% of HIV negative men aged 15-49y within 15
years would avert 3.4 million incident infections [10]. However, in priority countries, only up
to 30% of this target was reached in 2013 showing an estimated gap of 50% for uptake of
VMMC [10].
Recent UNAIDS targets aim to ensure that 90% of all PLWH are aware of their HIV status,
with 90% of those found HIV positive started onto ART [8]. Efforts to increase access to HTS
also provide an opportunity to ensure those men found HIV negative are offered VMMC. Of
more concern has been the finding that whilst HIV incidence decreased before 2010, it has
remained static since [11], highlighting the need to increase uptake of effective HIV treatment
and prevention strategies. One approach to increasing demand for HIV treatment and preven-
tion is through the use of financial incentives.
Financial incentives (FI) are a potential strategy for increasing demand for health services
by compensating users’ direct (e.g. transport) and indirect costs (e.g. opportunity cost of time)
[12]. Conditional FIs require a pre-specified action before receipt of the incentive [12], and
thus psychologically nudge individuals to prioritize health service utilization [13]. Recently
there has been significant interest in LMICs on using demand-side financial incentives
Financial incentives for linkage to HIV treatment and circumcision
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(DSFIs) to encourage desirable public health behaviours including for HIV [14]. DSFIs are
incentives offered to a specified target population (as opposed to providers of goods or ser-
vices) with the aim of increasing demand for goods or services of merit to that population [15].
Evidence in the literature suggests DSFIs can lead to increased use of preventive and treatment
services [16]. The use of DSFIs may be contributory to meet HIV treatment and prevention
goals in LMICs. We therefore conducted a systematic review and meta-analysis to investigate
the effect of DSFIs as an intervention in LMICs for increasing linkage into HIV treatment or
VMMC. We have not identified a meta-analysis specifically summarizing the effect of incen-
tives on linkage to care or VMMC thus far.
Materials and methods
A systematic literature review and meta-analysis of published and unpublished trials (PROS-
PERO 2015: CRD42015029248) was conducted [17]. For a trial to be eligible it had to be an
individually randomised controlled trial (RCT) or a cluster randomised trial (CRT) under-
taken in a low- and middle-income country (LMIC). There was no time or language restric-
tion. The review was restricted to LMICs because the epidemiology and management of HIV,
as well as the economic conditions in the region, differ substantially to other settings. Trials
were separated into two broad categories namely; studies investigating linkage into HIV treat-
ment (ART) and linkage into VMMC as two primary outcomes for this systematic review, and
a trial was included if it reported either of these two outcomes. These outcomes were not nec-
essarily primary outcomes in the original studies. We defined linkage to care as newly diag-
nosed HIV positive patients making at least one clinic visit where they could have been
assessed for ART eligibility and start ART within a specified period of time. Linkage to
VMMC was defined as undergoing the procedure within a specified period of time as indi-
cated by the study investigators. The rationale for choosing these two outcomes was that ART
and VMMC are the only proven effective interventions for reducing HIV transmission for
HIV positive and uncircumcised HIV negative men. While there are extant systematic reviews
reporting the effect of incentives for retention on ART, we did not find a systematic review
investigating the effect of financial incentives on linkage to ART or VMMC.
Types of interventions
This review included both conditional and unconditional DSFIs. Incentives included cash,
goods, vouchers or microfinance such as a loan (Table 1). Trials that offered supply-side finan-
cial incentives to health workers, for example to improve their performance, were excluded.
Table 1. Some financial incentives and their definitions.
Form of financial
incentive
Definition
Cash Hard cash given to the participant directly or indirectly e.g. via mobile money
Voucher Coupon given to participant or their representative to redeem e.g. at a shop, or to buy
airtime, or to cover part of the cost of a health good or service
Goods Anything tangible given to the participant e.g. soap, sweets, school uniform
Microfinance Any financial assistance given directly or indirectly to the participants or their
representative e.g. loan and school fees
https://doi.org/10.1371/journal.pone.0207263.t001
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Information sources and search strategy
Initial searches were done in MEDLINE and Cochrane library to determine if the review ques-
tion had already been addressed. We searched the title, abstract and keywords in eight biblio-
graphic databases in December 2016, namely: MEDLINE, EMBASE, Web of Science, Econlit,
Cochrane library, SCOPUS, international AIDS Society (IAS) and conference on retroviruses
and opportunistic infections (CROI) conference databases of abstracts. We also searched the
reference lists of all selected papers to see if any studies were missed. Review of abstracts from
two main HIV conferences and slides was done for conferences held between 2004 and 2016
to identify unpublished trials. This time restriction was for ease of searching purposes particu-
larly for online published abstract books for conferences. Record identification data were then
extracted and entered into an Excel database for initial screening.
Our search keywords comprised three main categories linked by ‘AND’, with keywords
within each category linked by ‘OR’ (Fig 1): keywords to restrict to LMIC using a search filter
based on World Bank 2014 definition of LMIC; keywords related to ART and VMMC; key-
words related to FIs (Table 1). Appropriate combination of key words and characters were
used for each database searched. The search strategy was initially piloted in Medline by AC to
determine the best approach.
Fig 1. Search Strategy consisting 3 main categories (low and middle income countries; HIV; and financial incentives).
https://doi.org/10.1371/journal.pone.0207263.g001
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Study selection
AC was responsible for running all the searches and removing duplicates from records.
Two reviewers (AC and SC) first reviewed titles and abstracts, and removed records that
were not relevant before doing full text review. If the abstract was judged by either
reviewer to be potentially relevant, a full text review was conducted. For conference
abstracts, the presentation slides were accessed from the conference website if available.
For inclusion in the final review, both reviewers reviewed all full articles/conference pre-
sentations, if both agreed, data were independently extracted and compared by both AC
and SC and any discrepancies resolved. A third reviewer (KF) resolved any lack of consen-
sus regarding inclusion of an article.
Data analysis and quality assessment
A PRSIMA flow diagram was used to provide detailed description of the review process
including the number of titles returned to trials that were finally included (Fig 2). Trials are
described with respect to setting, study population, outcomes and risk ratios (RRs) and 95%
confidence intervals (CI), as presented by the original authors of the trial. For trials that
reported odds ratios (OR) we converted these effect estimates into RRs in order to standardize
reporting across trials [18]. Meta-analysis was used to combine results from studies to investi-
gate heterogeneity and to obtain a summary RR, comparing interventions with FIs versus no
FIs (control). We used a random effects (RE) regression to estimate the summary RR and 95%
confidence interval (CI) and used forest plots to display estimates and 95% CIs, separately for
each of the two primary outcomes. Heterogeneity across the studies was assessed using the I2
statistic from the RE model. We added 0.5 in the numerator for trials with zero outcomes [19].
For trials with multiple intervention arms, we combined into one arm before pooling the esti-
mates using meta analysis [19].
The quality of studies included was assessed by AC and SC using the Downs and Black
checklist for randomised studies [20]. This is a score-based assessment tool with five different
domains: reporting, external validity, bias, confounding, and power with a maximum score of
32 across the domains.
Results
Search results
Of 1205 citations identified from searches in databases, conference abstracts and snowballing
titles and abstracts, 998 (82.8%) remained after removal of duplicates (Fig 2). A total of 950
citations were excluded after title and abstract screening because they reported other outcomes
(726) or they were in another disease area than HIV (224). A total of 48 articles had a full text
review of which nine were finally included in this systematic review (Fig 2). The majority (18/
39) of the full text articles excluded were non-randomised studies. Of the nine studies included
one was based on a conference abstract.
Description of included studies
Five trials investigated the effect of DSFIs on linkage to HIV treatment and four trials investi-
gated linkage to VMMC (Table 2). All studies included adult participants (age range: 18–70
years). Six of the nine studies were individually randomised, and all but one trial was under-
taken in sub-Saharan Africa. Trial sizes ranged from 86 to 2201 participants. Within a trial the
number of comparisons to the control arm ranged from one to five. The majority of trial arms
evaluated fixed (n = 10) incentives while some evaluated lottery based incentives (n = 2). Only
Financial incentives for linkage to HIV treatment and circumcision
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one trial provided cash incentives [21] while the rest implemented non-cash incentives includ-
ing mobile airtime as described in the protocol [22,23], food vouchers [24,25], smart phones
through raffle draw [26], and subsidy for the VMMC procedure fee [27].
In two studies, investigators provided a larger fixed amount incentive (e.g US$ 5) initially,
followed by a smaller (e.g. US$ 1) incremental incentive conditional on clinic attendance or
attainment of pre-specified goals [21,28]. In two trials [23,29], investigators compared the con-
trol arm to a complex intervention consisting of five components: point of care CD4; acceler-
ated ART initiation; telephone reminder; health information; and non-cash incentives (mobile
airtime) [22,23]. One trial, conducted among people who inject drugs (PWID), compared two
Fig 2. Flow diagram of search results.
https://doi.org/10.1371/journal.pone.0207263.g002
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incentives: the control arm offered a lottery prize equivalent to $4 with eligibility for the lottery
not conditional on meeting treatment targets, whilst the intervention arm offered non-cash
vouchers (US$4–8) conditional on meeting HIV treatment targets [28].
Table 2. Characteristics of included studies.
Author, year Country Type Sample
size
Arms Study
population
Outcomes Intervention (s)
Review outcome: linkage into
HIV treatment
Maughan-Brown, 2018 South Africa RCT 86 2 Adults referred for
ART
Mean age: 33
PO: Linkage to care in 3m
Uptake of treatment
following ART referral by a
mobile health clinic
US$23 conditional on starting
ART <3m
Elul, 2017 Mozambique CRT 2004 3† Newly diagnosed
HIV positive
Median age: 34
PO: Linkage to care in 1m
Retention at 12 months after
diagnosis
Combination of: point of care
CD4;
accelerated ART initiation; SMS
reminder;
health information; and airtime
incentive
Yotebieng, 2016 DR Congo RCT 433 2 Newly diagnosed
pregnant women
Age 29 (IQR 25–34)
PO: Retention at 6 weeks
postpartum
Uptake of PMTCT services
Acceptance of proposed
services postpartum‡
US$5, plus US$1 increment at
every subsequent clinic visit
McNairy, 2016 Swaziland CRT 2201 2 Newly diagnosed
HIV positive
Age 32 (IQR 26–40)
Linkage to care in 1 month
PO: Retention in care at 12m
Combination of: point of care
CD4;
accelerated ART initiation; phone
reminder;
health information; and airtime
incentive
Solomon, 2014 India RCT 120 2 HIV positive
Injecting drug users
Age 38 (IQR 32.5–
44)
PO: Linkage to care in 1m
Clinic visit in 12m eg refill
HIV RNA suppression at
12m
Control: Voucher incentives
through lottery
Intervention: Target-based
voucher incentives ($4 for linkage,
max $48 over 12m)
Review outcome: linkage into
voluntary medical male
circumcision (VMMC)
Thirumurthy, 2016 Kenya RCT 909 3 Uncircumcised men
Age 29.0 (SD: 6.0)
PO: VMMC uptake in 3m Intervention 1: Food voucher
($12.5)
Intervention 2: Lottery equivalent
of $12.50
Bazant, 2016 � Tanzania CRT � 2 Uncircumcised men
Age 27.6 (SD: 9.7)
PO: Number of VMMCs in
3m
Lottery: weekly smartphone raffle
Thirumurthy, 2014 Kenya RCT 1502 4 Uncircumcised men
Age range: 25–49
PO: VMMC uptake in 2m Fixed incentives: $2.5, $8.75, $15.0
Chinkhumba, 2014 Malawi RCT 1634 6 Uncircumcised men
Age 26.7 (SD: 5.8)
PO: VMMC uptake in 6m Fixed subsidy for VMMC
procedure:
(Full subsidy $6, $5.67, $5.3, $4.67,
$2.67, $0)
RCT: randomized controlled trial; CRT: cluster randomized trial; PMTCT: prevention of mother to child transmission; PO: primary outcome used by the original
authors (Italic: outcome used in this review); SD: standard deviation.
† Trial arm without a financial incentive not used in this review.
‡ Includes CD4 count testing.
� Trial not included in any further analysis due to lack of denominator data. Original analysis as difference in differences.
https://doi.org/10.1371/journal.pone.0207263.t002
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Quality assessment
Quality of the trials included were assessed as generally good, with Downs and Black scores
ranging from 19–29 out of a maximum of 32 (Table 3). For the unpublished study only the
abstract and conference presentation slides were assessed and we were unable to assess for
blinding, adverse events, loss to follow-up and adjustment for potential confounding factors
which resulted in a lower score [29]. Solomon et al. 2014 [28] had a slightly lower score (28)
due to potential selection bias because participants were drawn from individuals (drug users)
available to outreach providers. Such sampling frame may not represent the source population
as the majority of HIV patients who inject drugs in LMICs may not be in this patient category.
Chinkhumba et al. 2014 [27] had the lowest quality score of 16 because only p-values were
reported with no numerators and denominators and intervention effect estimates. Further-
more, there was no sample size section reported.
Linkage into HIV treatment
Of the 5 linkage to ART trials, 2 involved newly diagnosed HIV positive adults at the clinic;
one was among pregnant women attending postpartum services, one was among individuals
testing HIV positive during mobile HIV testing [30], and the final one was among PWID
(Table 2). Three trials found that FIs significantly improved linkage to ART as reported by the
original authors (Table 4). A FI significantly improved linkage to ART among women postpar-
tum in DR Congo (RR 1.26, 95% CI: 1.08; 1.48), as it did among PWID testing positive in an
outreach activity in India (RR 1.42, 95% CI: 1.09; 1.96). In Swaziland, a combination strategy
including a FI significantly improved linkage to HIV treatment by 10% (RR 1.10, 95% CI: 1.07;
1.14) among patients diagnosed at the clinic.
Two trials found that FIs did not significantly improve linkage to ART. One was among
people testing HIV positive in clinics in Mozambique (RR 0.96, 95% CI: 0.81; 1.16) while the
other was among newly diagnosed HIV positive individuals identified through a community
testing study (RR 0.82, 95% CI: 0.56; 1.22). There was considerable heterogeneity between the
five trials reporting on linkage to ART (I-squared of 89.2%, p< 0.001) and differences in study
populations, and so a pooled estimate is not reported (Fig 3).
Linkage into voluntary male medical circumcision (VMMC)
Among HIV negative men, fixed FIs appeared to improve the proportion of men undergoing
circumcision as reported by the original authors (Table 4). The proportion of HIV negative
Table 3. Quality assessment of the included studies.
Assessment domains
Author, year Reporting External
validity
Bias Confounding Power Maximum Score
Yotebieng 2016 9 3 6 6 5 29
McNairy, 2016 8 3 5 5 5 26
Solomon 2014 9 3 6 6 4 28
Thirumurthy, 2016 9 3 5 6 5 28
Bazant, 2016� 8 3 4 4 4 23
Thirumurthy, 2014 10 3 5 6 5 29
Chinkhumba, 2014 5 3 7 4 0 19
f Possible total score: Reporting (11); external validity (3); bias (7); confounding (6); power (5). Rated using the Downs and Black checklist.
� Trial not included in meta-analysis (Table 4) due to lack of denominator data. Original analysis as difference in differences
https://doi.org/10.1371/journal.pone.0207263.t003
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men who had circumcision was generally low in the studies with uptake ranging from 0.7% to
8.4% in intervention arms and 0–1.6% in control arms, over a follow-up period ranging from
2 to 6 months. However, the effect appeared stronger for higher compared with smaller values
of incentives [24]. For example, while USD15.0 improved uptake of circumcision within 2
Table 4. Trial outcomes: Linkage to ART and voluntary male medical circumcision.
Author, year Country Type Sample
size
Arms Study
population
Outcomes Intervention (s)
Review outcome: linkage into
HIV treatment
Maughan-Brown, 2018 South Africa RCT 86 2 Adults referred for
ART
Mean age: 33
PO: Linkage to care in 3m
Uptake of treatment
following ART referral by a
mobile health clinic
US$23 conditional on starting
ART <3m
Elul, 2017 Mozambique CRT 2004 3† Newly diagnosed
HIV positive
Median age: 34
PO: Linkage to care in 1m
Retention at 12 months after
diagnosis
Combination of: point of care
CD4;
accelerated ART initiation; SMS
reminder;
health information; and airtime
incentive
Yotebieng, 2016 DR Congo RCT 433 2 Newly diagnosed
pregnant women
Age 29 (IQR 25–34)
PO: Retention at 6 weeks
postpartum
Uptake of PMTCT services
Acceptance of proposed
services postpartum‡
US$5, plus US$1 increment at
every subsequent clinic visit
McNairy, 2016 Swaziland CRT 2201 2 Newly diagnosed
HIV positive
Age 32 (IQR 26–40)
Linkage to care in 1 month
PO: Retention in care at 12m
Combination of: point of care
CD4;
accelerated ART initiation; phone
reminder;
health information; and airtime
incentive
Solomon, 2014 India RCT 120 2 HIV positive
Injecting drug users
Age 38 (IQR 32.5–
44)
PO: Linkage to care in 1m
Clinic visit in 12m eg refill
HIV RNA suppression at
12m
Control: Voucher incentives
through lottery
Intervention: Target-based
voucher incentives ($4 for linkage,
max $48 over 12m)
Review outcome: linkage into
voluntary medical male
circumcision (VMMC)
Thirumurthy, 2016 Kenya RCT 909 3 Uncircumcised men
Age 29.0 (SD: 6.0)
PO: VMMC uptake in 3m Intervention 1: Food voucher
($12.5)
Intervention 2: Lottery equivalent
of $12.50
Bazant, 2016 � Tanzania CRT � 2 Uncircumcised men
Age 27.6 (SD: 9.7)
PO: Number of VMMCs in
3m
Lottery: weekly smartphone raffle
Thirumurthy, 2014 Kenya RCT 1502 4 Uncircumcised men
Age range: 25–49
PO: VMMC uptake in 2m Fixed incentives: $2.5, $8.75, $15.0
Chinkhumba, 2014 Malawi RCT 1634 7 Uncircumcised men
Age 26.7 (SD: 5.8)
PO: VMMC uptake in 6m Fixed subsidy for VMMC
procedure:
(Full subsidy $6, $5.67, $5.3, $4.67,
$2.67, $0)
RCT: randomized controlled trial; CRT: cluster randomized trial; PMTCT: prevention of mother to child transmission; PO: primary outcome used by the original
authors (Italic: outcome used in this review); SD: standard deviation, m: month.
† Trial arm without a financial incentive not used in this review.
‡ Includes CD4 count testing.
� Trial not included in any further analysis due to lack of denominator data. Original analysis as difference in differences.
https://doi.org/10.1371/journal.pone.0207263.t004
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months in Kenya, USD2.5 did not (RR 5.72,95% CI: 2.54; 12.25 and RR 1.10, 95% CI: 0.40; 3.18,
respectively) [24]. One study had a lottery FI arm (mean value of $12.5), as well as a fixed FI inter-
vention arm, but in contrast to the fixed FI, the lottery FI did not significantly improve the uptake
of VMMC within 3 months aRR 2.45 (95% CI: 0.80; 7.42) [25]. A trial offering five varying subsi-
dies for the circumcision procedure to uncircumcised men found that offering full subsidy (free
circumcision) increased uptake from 0.0% without subsidy to 3.0% [27] (Table 4).
One study was not included in meta-analysis because there were no denominators and the
outcome was VMMC increases analysed as a difference in differences that did not fit with the
overall analytical approach [26].
We estimate an overall 4-fold increase in the uptake of circumcision among HIV negative
uncircumcised men from our fitted RE model (Fig 4) with overall RR 4.00 (95% CI: 2.17; 7.37).
There was negligible heterogeneity in the estimates from the different studies with I-
squared = 0.0%; p = 0.923.
Discussion
The main finding from this systematic review was that demand-side financial incentives
(DSFIs) seemed to improve linkage to voluntary medical male circumcision (VMMC) but with
Fig 3. Forest plot of linkage to HIV treatment estimates. From meta-analysis of the data reported by the original authors (Table 4). Form: mode of giving financial
incentive.
https://doi.org/10.1371/journal.pone.0207263.g003
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unclear effect on linkage to HIV treatment in low and middle income countries. It is unclear why
financial incentives worked better for the VMMC outcome compared to the linkage to ART out-
come. The age and sex profile of participants in the included trials was very similar (Table 5),
although all three VMMC trials among men reported significant improvement. A potential
Fig 4. Forest plot of linkage to voluntary medical male circumcision (VMMC) estimates. From meta-analysis of the data reported by the original authors (Table 4).
Form: mode of giving financial incentive.
https://doi.org/10.1371/journal.pone.0207263.g004
Table 5. Characteristics of participants in the included studies.
Male Female Age Employed?
Author, year n (%) n (%) Estimate (variation) Yes (n, %) Type of incentive
Linkage to HIV treatment trials
Maughan-Brown, 2018 31 (36.0) 55 (64.0) Mean: 33.0 28 (32.6%) Voucher
Elul, 2017 712 (36.0) 1,292 (64.0) Median: 34.0 1,473 (74.0) Air time
Yotebieng, 2016 0 (0.0) 433 (100) 29 (IQR 25–34) Not reported Cash
McNairy, 2016 903 (41.1) 1,294 (58.9) 31 (IQR 26–39) 1042 (47.4) Air time
Solomon, 2014 109 (90.8) 11 (9.2) Median: 38 102 (85.0) Voucher
Linkage to HIV voluntary medical male circumcision trials
Thirumurthy, 2016 909 (100) 0 (0.0) Mean: 29 (SD: 5.9) Not reported Food voucher
Thirumurthy, 2014 1502 (100) 0 (0.0) Mean: 34.4 (SD: 6.7) Not reported Food voucher
Chinkhumba, 2014 1634 (100) 0 (0.0) Mean: 26.7 (SD: 5.8) Not reported Subsidy
https://doi.org/10.1371/journal.pone.0207263.t005
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explanation is that the targeted study populations may perceive VMMC differently from linkage
to ART. While linkage to ART implies a lot of additional steps some of which may imply disclo-
sure of being HIV positive, VMMC is a one-off procedure. This implies that VMMC uptake may
be higher as it is not associated with stigma in the same way linkage to ART may be. We note that
although FIs increased linkage to VMMC, the numbers were still very small, for example absolute
differences were small despite large relative risks.
Most studies provided fixed FIs (cash, food vouchers, mobile airtime) of varying levels and
only one study had a lottery arm. We identified few studies that investigated the use of FIs to
improve linkage to HIV treatment or VMMC in LMICs, and the amount of the incentive was
found to determine effectiveness. The findings highlight the value of using FIs for increasing
demand for HIV treatment and prevention services in the region, especially where healthcare
providers may be exploring approaches to rapidly scale up coverage of these services.
The WHO recently emphasized the need for closer integration of HIV prevention services
to HIV testing services, particularly VMMC and pre-exposure prophylaxis (PrEP) [1]. VMMC
has been shown to be potentially cost saving at scale [31] and ensuring high levels of coverage
in countries facing a generalized HIV epidemic has the potential to avert millions of new HIV
infections [31]. However, recent estimates suggest over 20 million young adults are still to be
reached by VMMC services in high priority countries [11]. The evidence from this systematic
review suggests there is a potential role of DSFIs to meet these goals in LMICs hardest hit by
the HIV pandemic [1]. VMMC does not require adults to attend health facilities multiple
times over long-time periods, which may explain why DSFIs were found to increase demand.
Previous studies have found FIs may be more effective for simpler than complex behavioral
change [32,33]. The value of incentives given in the studies reviewed ($2.50 to $15.0) was con-
siderably lower than previously estimated costs for performing VMMC ($ 75–95 in 2010
prices) [31]. Although providing FIs may increase VMMC intervention costs, the resulting
increase in uptake of VMMC may still result in the intervention being cost-effective. It is
important to note that even with FIs, VMMC uptake only increased by 9%, implying that
other strategies than FIs may be needed to address residual barriers [27]. Thirumurthy et. al
[24] and Chinkhumba et. al [27] provide important insight into the dosing effect of FIs. The
authors found that unless the incentive exceeded a certain threshold value, it was not found to
be effective. This suggests that careful assessment of the size of the incentive on offer is war-
ranted if incentives are to be effective.
We were intrigued by the apparent lack of effect by lottery-type of incentives as these have
been shown to work in other settings albeit in different disease areas [34]. Lottery-based FIs
have also been shown to reduce HIV incidence within the African region by influencing sexual
behaviour patterns [35]. One study–and only one arm investigated this intervention, hence
more studies may be required to understand the impact of lottery interventions. The theory
behind lottery is that individuals tend to overestimate the probability to win and thus are more
likely to take the risk [36].
Although only three of the five trials investigating DSFIs showed improvement in linkage
to care, we note that the actual linkage proportions were high in the intervention arms of the
trials: 55.0–92.0% [21,28,29], and in control arms with range: 34.9–83.0%. It was interesting to
note that among PWID, a fixed incentive was more effective than the control with a lottery
intervention at increasing linkage. Furthermore, 50% of participants receiving the fixed incen-
tive linked to clinic within 5 days of randomisation [28]. This is an important finding as it sug-
gests that DSFIs can be used to improve rapid linkage [37] which may lead to earlier viral
suppression and therefore long term good health, especially in patients with low CD4 count
(<500 cells/μ) [38].
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There are a number of limitations with this systematic review. First, we broadly categorized
incentives as fixed or lottery which may lack directness on what specific type of incentive
(cash, voucher, gift, or subsidy) may be more effective. However, a recent comparison of cash
vs voucher incentives concluded that cash incentives were more preferred by both the program
and recipients in a humanitarian aid context in DRC [39]. Second, for linkage to VMMC, out-
comes were measured over different follow-up periods, an element not accounted for in the
analysis. Third, we included one trial whose linkage to HIV treatment outcome only included
attendance for CD4 count which may not necessarily mean initiation of HIV treatment.
Fourth, we included two trials offering a combination of several interventions including a
financial incentive. As the financial incentive was only a part of the combination strategy, it
may not be possible to isolate the incremental effect of the financial incentive alone. Finally,
some trials may have been missed because the search key words did not include ART, or
because the primary outcome of the review was not the primary outcome of the original trials.
HIV testing is seen as key to ensuring universal access to HIV treatment and prevention
services, however, linkage into these services after HIV testing remains sub-optimal. In this
systematic review we found the use of DSFIs significantly improved linkage into HIV treat-
ment and the uptake of VMMC in LMICs. As HIV testing services are being scaled-up across
LMICs to meet UNAIDS targets, healthcare providers in countries where ART and VMMC
coverage remains low may need to consider offering FIs to increase demand. Further work is
needed to explore the use of FIs along the HIV cascade of services from testing, linkage to viral
suppression.
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